Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
academia, alleviating, arm, AstraZeneca, auranofin, azathioprine, biyearly, blinded, breadth, Career, clarity, collapse, condensed, conference, confirm, confirmatory, confirmed, cyclosporine, deducting, deliverable, Denver, drawn, element, enriched, EP, Ethische, EU, Evaluatie, faculty, fluctuation, fostamatinib, fuller, fusion, gastrointestinal, Geneesmiddelen, geographic, GSK, hACR, hoc, Huntsville, hybrid, hydroxychloroquine, induction, insightful, lapse, Leerink, living, matching, Medisch, Mexico, MHRA, mild, mix, moderate, multinational, nadir, Nektar, OHQ, OHSA, overseeing, OXiGENE, packaging, PD, penicillamine, Pennsylvania, political, postdialytic, power, preceding, principle, protein, QUALITATIVE, question, recovered, refunded, regional, reopening, retrospective, retrospectively, robust, rueckert, scarcity, Schiff, seventeen, Stichting, subgroup, subspecialist, suitable, sulfaszlazine, tablet, tasocitinib, taxable, textbook, Therapeutische, titrated, titration, Toetsingscommissie, Traditional, ulcerative, unblinded, underwent, UNRESOLVED, Utrecht, voluntary, walking, week
Removed:
abdominal, Adjunct, AF, altered, arrangement, ascertain, assumed, Attending, Baptist, Bethesda, CBER, Celltech, CME, coauthor, Cohen, committed, cytotoxic, diarrhea, discussing, DNA, dropping, dyspepsia, EITF, England, equivalency, FIN, formation, grouped, Harold, hired, Interpretation, investor, invited, Irving, length, loading, Memorial, monographThe, Mt, nondiabetic, organ, Parkland, Paul, prescribed, Profession, pulmonary, Radiant, reach, reformulated, Researchand, speaker, St, Stanley, suggesting, symposia, Task, UK, UTSWMC
Filing tables
Filing exhibits
- 10-K Annual report
- 3.1 Certificate of Incorporation As Amended on May 28, 2009
- 23.1 Consent of Independent Registered Public Accounting Firm
- 23.2 Consent of Independent Registered Public Accounting Firm
- 31.1 Certification of Chief Executive Officer
- 31.2 Certification of Chief Financial Officer
- 32.1 Certification of CEO Pursuant to Section 906
- 32.2 Certification of CFO Pursuant to Section 906
CHTP similar filings
Filing view
External links
EXHIBIT 23.2
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the registration statements on Forms S-3 (Nos. 333-132330, 333-141964, 333-146422 and 333-161236) and Forms S-8 (Nos. 333-137782, 333-144061 and 333-160256) of our report dated March 10, 2008 relating to the consolidated financial statements of Chelsea Therapeutics International, Ltd. and included in this Annual Report on Form 10-K of Chelsea Therapeutics International, Ltd. for the year ended December 31, 2009.
/s/ J.H. Cohn LLP
Roseland, New Jersey
March 10, 2010